دورية أكاديمية

Update on Transcatheter Device Closure of Congenital Septal Defects.

التفاصيل البيبلوغرافية
العنوان: Update on Transcatheter Device Closure of Congenital Septal Defects.
المؤلفون: Wood KP; Division of Pediatric Cardiology, Duke University, Durham, USA., Fleming GA; Division of Pediatric Cardiology, Duke University, Durham, USA., Chamberlain RC; Division of Pediatric Cardiology, Duke University, Durham, USA. reid.chamberlain@duke.edu.
المصدر: Current cardiology reports [Curr Cardiol Rep] 2023 Sep; Vol. 25 (9), pp. 1083-1093. Date of Electronic Publication: 2023 Jul 31.
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: Current Science Country of Publication: United States NLM ID: 100888969 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-3170 (Electronic) Linking ISSN: 15233782 NLM ISO Abbreviation: Curr Cardiol Rep Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Philadelphia, PA : Current Science, c1999-
مواضيع طبية MeSH: Heart Septal Defects, Atrial*/surgery , Heart Septal Defects, Ventricular*/surgery , Pulmonary Arterial Hypertension* , Septal Occluder Device*, Child ; Humans ; Heart Ventricles ; Length of Stay ; Cardiac Catheterization/methods ; Treatment Outcome
مستخلص: Purpose of Review: The goal of this paper is to review currently available devices for closure of atrial septal defects (ASDs) and ventricular septal defects (VSDs).
Recent Findings: Favorable results from the ASSURED trial resulted in FDA approval for the most recently developed device for transcatheter ASD closure in the United States. Further studies are required to assist in the development or approval of safe devices for transcatheter perimembranous VSD closure in pediatric patients. Device closure is the less invasive and preferred management option for many ASDs, with multiple studies demonstrating lower complication rates, shorter hospital stays, and lower mortality than surgical repair. Complex ASDs that make device closure more difficult include large defects, rim deficiencies, fenestrated defects, multiple defects, and the presence of pulmonary arterial hypertension. Device closure has also become an accepted alternative to surgery for some types of ventricular septal defects VSDs, though challenges and limitations remain. Future innovations including novel devices and techniques are needed to further expand on the types of defects that can be safely closed via transcatheter approach.
(© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
فهرسة مساهمة: Keywords: Atrial septal defect; Device closure; Transcatheter intervention; Ventricular septal defect
تواريخ الأحداث: Date Created: 20230731 Date Completed: 20230831 Latest Revision: 20230905
رمز التحديث: 20240829
DOI: 10.1007/s11886-023-01925-3
PMID: 37523002
قاعدة البيانات: MEDLINE
الوصف
تدمد:1534-3170
DOI:10.1007/s11886-023-01925-3